Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001704336-26-000005

President & CEO acquired 218,050 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cloonan Michael · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2026-09-17 Grant or award : show line 1 in the form +109,025 656,368 D
2026-09-17 Grant or award : show line 2 in the form +109,025 765,393 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-09-17 Grant or award : show line 3 in the form Non-Qualified Stock Option (right to buy) +436,100 436,100 D
2026-09-17 Returned to the company : show line 4 in the form Non-Qualified Stock Option (right to buy) −436,100 0 D
Loading xslF345X06/edgardoc.xml…